[Involvement of tetrahydrobiopterin in local change of endothelium-dependent vasorelaxation in pulmonary hypertension].
D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D008168:Lung / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism; D008297:Male; D016686:Monocrotaline / Q000633:toxicity; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D011651:Pulmonary Artery / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D001708:Biopterins; D016686:Monocrotaline; D019001:Nitric Oxide Synthase; C003402:sapropterin; D010100:Oxygen
Uchastie tetragidrobiopterina v lokal'nom izmenenii éndoteliĭzavisimogo rasslableniia sosudov pri legochnoĭ gipertenzii.